MENLO PARK, Calif.--(BUSINESS WIRE)--TriplePoint Venture Growth BDC Corp. (NYSE: TPVG) (the “Company”) today
announced that it is offering, subject to market and other conditions,
notes due 2022 (the “Notes”) in an underwritten public offering.

The Company intends to list the Notes on the New York Stock Exchange and
expects trading to commence thereon within 30 days of the original issue
date. The interest rate and other terms of the Notes will be determined
at the time of pricing of the offering.

The Company expects to use the net proceeds from this offering to redeem
all of the outstanding indebtedness under its 6.75% fixed-rate notes due
2020 (the “2020 Notes”), which currently amounts to approximately $54.6
million plus accrued and unpaid interest. The Company expects to use any
remaining proceeds after redemption of the 2020 Notes to repay
outstanding borrowings under its $200 million revolving credit facility.

This press release does not constitute an offer to sell or the
solicitation of an offer to buy the securities in this offering or any
other securities nor will there be any sale of these securities or any
other securities referred to in this press release in any state or
jurisdiction in which such offer, solicitation or sale would be unlawful
prior to the registration or qualification under the securities laws of
such state or jurisdiction.

A shelf registration statement relating to these securities is on
file with and has been declared effective by the Securities and Exchange
Commission. The offering may be made only by means of a prospectus and a
related prospectus supplement, copies of which may be obtained, when
available, from any of the following investment banks: Keefe, Bruyette &
Woods, Inc., Attn: Debt Capital Markets, 787 Seventh Avenue, Fourth
Floor, New York, NY 10019 (telephone number 1-800-966-1559); or Morgan
Stanley & Co. LLC, Attn: Prospectus Department, 180 Varick Street, 2nd
Floor, New York, NY 10014; or Deutsche Bank Securities Inc., Attn:
Prospectus Group, 60 Wall Street, New York, New York 10005-2836, or by
emailing prospectus.cpdg@db.com
(telephone number 1-800-503-4611).

The preliminary prospectus supplement, dated July 11, 2017, and
accompanying prospectus, dated April 26, 2017, each of which has been
filed with the Securities and Exchange Commission, contain a description
of these matters and other important information about theCompany
and should be read carefully before investing. Investors are advised to
carefully consider the investment objectives, risks and charges and
expenses of the Company before investing.

About TriplePoint Venture Growth BDC Corp.

The Company serves as the primary financing source for the venture
growth stage business segment of TriplePoint Capital LLC, the leading
global provider of financing across all stages of development to
technology, life sciences and other high growth companies backed by a
select group of venture capital firms. The Company’s investment
objective is to maximize its total return to stockholders primarily in
the form of current income and, to a lesser extent, capital appreciation
by primarily lending with warrants to venture growth stage companies.
The Company is an externally managed, closed-end, non-diversified
management investment company that has elected to be regulated as a
business development company under the Investment Company Act of 1940,
as amended.

Forward Looking Statements

Certain statements contained in this press release constitute
forward-looking statements, including statements with regard to the
Company’s securities offering and the anticipated use of net proceeds of
the offering. Forward-looking statements are not guarantees of future
performance, condition or results and involve a number of substantial
risks and uncertainties, many of which are difficult to predict and are
generally beyond the Company's control. Words such as "anticipates,"
"expects," "intends," "plans," "will," "may," "continue," "believes,"
"seeks," "estimates," "would," "could," "should," "targets," "projects,"
and variations of these words and similar expressions are intended to
identify forward-looking statements. Actual results may differ
materially from those in the forward-looking statements as a result of a
number of factors, including those described from time to time in the
Company’s filings with the Securities and Exchange Commission, including
the final prospectus supplement that will be filed with the Securities
and Exchange Commission. The Company undertakes no obligation to
publicly update or revise any forward-looking statements, whether as a
result of new information, future events or otherwise, except as may be
required by law.